Johnson & Johnson (FRA:JNJ)
€ 138.92 -0.18 (-0.13%) Market Cap: 334.68 Bil Enterprise Value: 341.56 Bil PE Ratio: 9.88 PB Ratio: 5.15 GF Score: 83/100

Q2 2021 Johnson & Johnson Earnings Call Transcript

Jul 21, 2021 / 12:30PM GMT
Release Date Price: €143 (-0.47%)
Operator

Good morning, and welcome to Johnson & Johnson's Second Quarter 2021 Earnings Conference Call. (Operator Instructions) The call is being recorded. If anyone has any objections, you may disconnect at this time. (Operator Instructions)

I would now like to turn the conference call over to Johnson & Johnson. You may begin.

Christopher DelOrefice
Johnson & Johnson - VP of IR

Good morning. This is Chris DelOrefice, Vice President of Investor Relations for Johnson & Johnson. Welcome to our company's review of business results for the second quarter and our updated financial outlook for 2021.

Joining me on today's call is Joe Wolk, Executive Vice President, Chief Financial Officer. Also joining Joe and myself in the Q&A portion of the call will be Jennifer Taubert, Executive Vice President and Worldwide Chair, Pharmaceuticals; Thibaut Mongon, Executive Vice President and Worldwide Chair, Consumer Health; and Ashley McEvoy, Executive Vice President and Worldwide Chair, Medical Devices.

A few logistics before we get into

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot